Exhibit 99.1
Market Announcement
6 February 2025
Alterity Therapeutics Limited (ASX: ATH) – Trading Halt
Description
The securities of Alterity Therapeutics Limited (‘ATH’) will be placed in trading halt at the request of ATH, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Monday, 10 February 2025 or when the announcement is released to the market.
Issued by
ASX Compliance
| 6 February 2025 | Market Announcement 1/1 | |
| ASX Limited | ASX Customer Service Centre 131 279 | asx.com.au |
6 February 2025
By email: melissa.kostopoulos@asx.com.au
Melissa Kostopoulos
Adviser, Listings Compliance (Melbourne) ASX Limited
Dear Melissa
Request for a trading halt
Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE) (the Company), requests that the Company’s securities be placed into a trading halt with immediate effect.
For the purposes of Listing Rule 17.1, the Company provides the following information:
| 1. | the Company is seeking the trading halt pending an announcement in relation to a capital raising; |
| 2. | the Company requests that the trading halt continues until the earlier of it making an announcement regarding the capital raising or until the commencement of trading on Monday 10 February 2025; and |
| 3. | the Company is not aware of any reason why the trading halt should not be granted or of any other information necessary to inform the market about the trading halt. |
Please contact us should you have any questions.
Yours sincerely
| /s/ Abby Macnish Niven |
Abby Macnish Niven
Company Secretary
For and on behalf of the Board of Alterity Therapeutics Limited
Alterity Therapeutics Limited
Level 3, 460 Bourke Street, Melbourne, VIC 3000 Australia
T: +61 (0)3 9349 4906 | WWW.alteritytherapeutics.com